Selected References:
- Bryant Ranch Prepack. 2024. Hydroxyzine Hydrochloride Product Label. Available at: https://www.accessdata.fda.gov/spl/data/897a39b6-65b1-4e52-85e9-2650d23a4dc0/897a39b6-65b1-4e52-85e9-2650d23a4dc0.xml. Accessed 14 April 2025.
- Calderon-Margalit, R., Qiu, C., Ornoy, A., Siscovick, D. S., & Williams, M. A. 2009. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. American journal of obstetrics and gynecology, 201(6), 579.e1–579.e5798.
- Diav-Citrin O, et al. 2003. Pregnancy outcome after gestational exposure to loratidine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol 111:1239-1243.
- Earl FL, et al. 1973. Teratogenic research in beagle dogs and miniature swine. Lab Anim Drug Test Symp Int Comm Lab Anim, 5th Fischer, Stuttgart pp. 233-247.
- Einarson A, et al. 1997. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 78:183-186.
- Erez S, et al. 1971. Double-blind evaluation of hydroxyzine as an antiemetic in pregnancy. J Reprod Med 7:57-59.
- Ito S, et al. 1993. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. Am J Obstet Gynecol 168:1393-1399.
